Trade Alector, Inc. - ALEC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.46 |
| Open | 6.48 |
| 1-Year Change | 4.85% |
| Day's Range | 6.32 - 6.56 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 6.46 | 0.14 | 2.22% | 6.32 | 6.64 | 6.13 |
| Jul 24, 2024 | 6.31 | -0.09 | -1.41% | 6.40 | 6.53 | 6.28 |
| Jul 23, 2024 | 6.55 | 0.17 | 2.66% | 6.38 | 6.76 | 6.25 |
| Jul 22, 2024 | 6.35 | 0.64 | 11.21% | 5.71 | 6.41 | 5.71 |
| Jul 19, 2024 | 5.80 | 0.09 | 1.58% | 5.71 | 5.86 | 5.68 |
| Jul 18, 2024 | 5.80 | 0.06 | 1.05% | 5.74 | 6.05 | 5.74 |
| Jul 17, 2024 | 5.82 | -0.14 | -2.35% | 5.96 | 6.05 | 5.72 |
| Jul 16, 2024 | 6.04 | 0.30 | 5.23% | 5.74 | 6.05 | 5.74 |
| Jul 15, 2024 | 5.71 | 0.18 | 3.25% | 5.53 | 5.88 | 5.46 |
| Jul 12, 2024 | 5.51 | 0.10 | 1.85% | 5.41 | 5.76 | 5.39 |
| Jul 11, 2024 | 5.38 | 0.23 | 4.47% | 5.15 | 5.47 | 5.14 |
| Jul 10, 2024 | 4.99 | 0.28 | 5.94% | 4.71 | 5.02 | 4.71 |
| Jul 9, 2024 | 4.74 | 0.19 | 4.18% | 4.55 | 4.80 | 4.47 |
| Jul 8, 2024 | 4.58 | 0.18 | 4.09% | 4.40 | 4.60 | 4.39 |
| Jul 5, 2024 | 4.37 | 0.10 | 2.34% | 4.27 | 4.38 | 4.27 |
| Jul 3, 2024 | 4.38 | 0.13 | 3.06% | 4.25 | 4.51 | 4.25 |
| Jul 2, 2024 | 4.32 | -0.03 | -0.69% | 4.35 | 4.39 | 4.20 |
| Jul 1, 2024 | 4.40 | -0.09 | -2.00% | 4.49 | 4.61 | 4.38 |
| Jun 28, 2024 | 4.52 | -0.03 | -0.66% | 4.55 | 4.57 | 4.36 |
| Jun 27, 2024 | 4.51 | 0.27 | 6.37% | 4.24 | 4.55 | 4.20 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Alector, Inc. Company profile
About Alector Inc
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. The Company has advanced four product candidates, AL001, AL002, AL003, and AL101, into clinical development. Its first product candidate, AL001, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients. Its AL002 targets triggering receptor expressed on myeloid cells 2 (TREM2) to increase the functionality of TREM2 signaling and enhance microglia cell activation.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Alector Inc revenues increased from $21.1M to $207.1M. Net loss decreased 81% to $36.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects General and administrative - Balancing decrease of 19% to $35.7M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$2.45 to -$0.45.
| Industry: | Bio Therapeutic Drugs |
131 Oyster Point Blvd., Suite 600
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com